Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib

Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib

Stereotactic body radiotherapy (SBRT) has shown promising results in the control of macroscopic vascular invasion in patients with hepatocellular carcinoma (HCC); however, its efficacy in comparison to sorafenib when combined with transarterial chemoembolization (TACE) remains to be determined. Betw...

Full description

Bibliographic Details
Main Authors: Lujun Shen, Mian Xi, Lei Zhao, Xuhui Zhang, Xiuchen Wang, Zhimei Huang, Qifeng Chen, Tianqi Zhang, Jingxian Shen, Mengzhong Liu, Jinhua Huang
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Cancers
Subjects:
hepatocellular carcinoma
macrovascular invasion
stereotactic body radiotherapy
sorafenib
transarterial chemoembolization
Online Access:https://www.mdpi.com/2072-6694/10/12/516

Similar Items

Similar Items